Investor Relations

OPKO Surpasses 50% Enrollment in First Phase 3 Trial of RayaldyTM (CTAP101 Capsules) more »

OPKO Announces First Quarter 2013 Operating and Financial Highlights more »

OPKO Health To Acquire PROLOR Biotech more »

OPKO Health Acquires Interest in Growing Russian Pharmaceutical Company more »

SEC Filings

  
Filing Description Date Filed Size Sorted Ascending View  
4 eichler, david a Sep 21, 2007 22.0 KB View HTML View PDF View XLS  
4 beier, thomas e Jan 28, 2008 22.4 KB View HTML View PDF View XLS  
4 lerner, richard a Sep 21, 2007 22.0 KB View HTML View PDF View XLS  
4/A spencer david lee Apr 4, 2006 21.9 KB View HTML View PDF View XLS  
4/A spencer david lee Apr 4, 2006 21.9 KB View HTML View PDF View XLS  
4/A spencer david lee Apr 4, 2006 21.9 KB View HTML View PDF View XLS  
4/A spencer david lee Apr 5, 2006 21.9 KB View HTML View PDF View XLS  
4/A spencer david lee Apr 4, 2006 21.9 KB View HTML View PDF View XLS  
4 reich, michael Aug 5, 2008 18.8 KB View HTML View PDF View XLS  
4 beier, thomas e Jun 11, 2009 18.9 KB View HTML View PDF View XLS  
4/A paganelli john a Apr 4, 2006 22.3 KB View HTML View PDF View XLS  
4/A paganelli john a Apr 4, 2006 22.4 KB View HTML View PDF View XLS  
4/A paganelli john a Apr 4, 2006 22.4 KB View HTML View PDF View XLS  
4/A paganelli john a Apr 4, 2006 22.3 KB View HTML View PDF View XLS  
4 benou, robert s Feb 4, 2005 31.7 KB View HTML View PDF View XLS  
4 lerner, richard a Aug 5, 2008 18.8 KB View HTML View PDF View XLS  
4 benou, robert s Nov 16, 2004 31.8 KB View HTML View PDF View XLS  
4 benou, robert s Jun 8, 2005 30.2 KB View HTML View PDF View XLS  
4 benou, robert s Aug 18, 2005 30.2 KB View HTML View PDF View XLS  
4 goldschmidt, pascal j Jun 11, 2009 19.1 KB View HTML View PDF View XLS  
Showing 101-120 of 1304 Page: 1 2 3 4 5 6 7 8 9 10 ... 66  Previous 20 | Next 20